Quantcast

Latest pharmaceutical industry Stories

2014-06-26 08:28:02

BOSTON, June 26, 2014 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company"), a provider of pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry, today announced that it has been added to the preliminary list for the Russell Microcap Index, to be finalized on June 27, 2014. The new membership lists for Russell Indexes are available at...

2014-06-26 08:27:25

MONMOUTH JUNCTION, N.J., June 26, 2014 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company focused on developing innovative technology-based products announced two key additions to its' executive team: Sally A. Berry, MD, PhD will join as Chief Medical Officer and Norma Cappetti will join as Vice President of Regulatory Affairs. Dr. Berry is a Board Certified Psychiatrist with a distinguished career in Medical Affairs and Clinical Development of many leading products....

2014-06-25 16:26:11

DUBLIN, June 25, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/zkqjjm/membrane) has announced the addition of the "2014 Report on the International Membrane Technology (Pharmaceutical, Biopharma and Life Sciences) Market - Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Membrane technology is widely used in various development phases of pharmaceutical, biopharmaceutical and life sciences industries....

2014-06-25 08:32:49

ELLICOTT CITY, Md., June 25, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) is proud to announce the launch of the inaugural Site Patient Recruitment Innovation Award (SPRIA), to recognize and honor highly effective patient enrollment strategies at clinical research sites. "Optimizing patient enrollment is something the sites and industry both view as critical," says Christine Pierre, President, SCRS. "In creating the SPRIA, SCRS seeks to recognize top performing...

2014-06-25 08:31:19

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Colorectal Cancer, Melanoma and Cancer Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/triple_analysis_colorectal_cancer_melanoma_cancer_vaccines.html This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is...

2014-06-25 08:31:17

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Leukemia, Melanoma and Cancer Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/triple_analysis_leukemia_melanoma_cancer_vaccines.html This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated according to...

2014-06-25 08:31:13

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Lymphoma, Melanoma and Cancer Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/triple_analysis_lymphoma_melanoma_cancer_vaccines.html This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated according to...

2014-06-25 08:30:55

GREENWOOD VILLAGE, Colo., June 25, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that it has informed the Transplant and Ophthalmology Division of the FDA of its intent to reduce the patient sample size in the OptimEyes Study for the treatment of Diabetic Macular Edema (oral treatment with Optina(TM)). This trial was intended to enroll 450 patients and was powered at 95%. The present enrollment of over 355 patients provides an adequate power of 88%,...

2014-06-25 08:30:28

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Leukemia, Lung Cancer and Melanomahttp://www.reportbuyer.com/pharma_healthcare/diseases/triple_analysis_leukemia_lung_cancer_melanoma.html This triple analysis focuses on cancer drug development strategies in Leukemia, Lung Cancer and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment...

2014-06-24 23:16:24

PINNAKLE uncovers unrealized brand opportunity in the pharma industry. New York, NY (PRWEB) June 24, 2014 Kantar Health, a leading global healthcare consulting firm, today announced the introduction of PINNAKLE™, an integrated, holistic brand marketing solution that helps pharmaceutical companies maximize commercial success for their medicines by finding their unrealized brand opportunity. A unique and revolutionary approach, PINNAKLE optimizes brand performance through the seamless...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related